Want to see IN:IPCALAB full AI Analyst Report?
IPCA Laboratories Limited (IPCALAB) Revenue
IPCA Laboratories Limited Revenue
IPCA Laboratories Limited had a revenue of 23.88B in the quarter ending Mar 31, 2026, with -0.17%. This bring the company's revenue in the last twelve months to 96.46B, Increased 1.47%. In the fiscal year ending Mar 31, 2026, IPCA Laboratories Limited had annual revenue of 96.46B with 7.89% growth.
- Revenue (ttm)
- 96.46B
- Revenue Growth
- 10.59%
- P/S Ratio
- 5.07
- Revenue/Employee
- INR 5,605,073
- Employees
- 17,210
- Market Cap
- INR 488.98B
Revenue Chart
IPCA Laboratories Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 96.46B | 7.05B | 7.89% |
| Mar 31, 2025 | 89.41B | 12.35B | 16.03% |
| Mar 31, 2024 | 77.06B | 14.58B | 23.33% |
| Mar 31, 2023 | 62.48B | 4.18B | 7.16% |
| Mar 31, 2022 | 58.30B | 4.10B | 7.56% |
| Mar 31, 2021 | 54.21B | 7.71B | 16.58% |
| Mar 31, 2020 | 46.50B | 8.75B | 23.18% |
| Mar 31, 2019 | 37.75B | 4.90B | 14.91% |
| Mar 31, 2018 | 32.85B | 1.29B | 4.09% |
| Mar 31, 2017 | 31.56B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:IPCALAB | 96.46B |
| IN:AJANTPHARM | 57.76B |
| IN:EMCURE | 42.98B |
| IN:NEULANDLAB | 23.72B |
| IN:WOCKPHARMA | 35.64B |